Articles

Stem cells: Taking stock in Stockholm

ISSCR will hold 2015 annual meeting in Sweden as part of its ‘great vision’ of global activity
Written byLloyd Dunlap
| 15 min read

13th International Society for Stem Cell Research (ISSCR) Annual Meeting

Stockholmsmässan Exhibition and Convention Center
Stockholm, Sweden

June 24-27, 2015

STOCKHOLM, Sweden—The Skokie, Ill.-based International Society for Stem Cell Research (ISSCR) will be headed across the Atlantic for its 13th annual meeting, which will take place June 24-27, 2015, at the Stockholmsmässan Exhibition and Convention Center in Stockholm. Some 4,000 stem cell scientists, bioethicists, clinicians and industry professionals from over 50 countries are expected to show up to present, discuss and learn about the latest discoveries and technologies within the field.

“The ISSCR is excited to bring its annual meeting to Stockholm, a city that shares our passion and reputation for great scientific research and collaboration,” says ISSCR President Dr. Rudolf Jaenisch of the Whitehead Institute for Biomedical Research. “We look forward to learning more about the strong work being done in Sweden and across Europe.”

Jaenisch notes that Chicago-area ISSCR was founded with “great vision” and that the annual meeting not simply being in the United States is key to its worldwide activities. In just the 13 years leading up to this Swedish venue, he points out that the annual meeting has been held twice in Canada—Vancouver last year and also Toronto—and in Japan, Australia and Spain.

Importantly, this year’s meeting is co-sponsored by Sweden’s Wallenberg Institute of Regenerative Medicine (WIRM). WIRM is very active in planning, networking and outreach programs that will contribute to the meeting’s success, Jaenisch notes. In addition, WIRM will host a symposium at the medical university Karolinska Institutet during the annual meeting. This year’s public symposium, “Stem Cells and the Ageing Brain,” will take place June 23, from 5 p.m. to 8 p.m. in the Aula Medica lecture hall at Karolinska Institutet. The symposium is open to the public and free of charge.

WIRM is a research institute financed by a research grant from Knut och Alice Wallenbergs Stiftelse. The aim of WIRM is to advance research on the blood system at Karolinska Institutet, both during normal hematopoietic development and in disease. This is accomplished by recruitment of leading international expertise, both at the senior level and at the level of new junior group leaders. WIRM also builds new important research infrastructure for stem cell research and regenerative medicine, including a state-of-the-art fluorescent-activated cell sorting facility supporting core facilities for cellular reprogramming/induced pluripotent stem cells, GMP production of clinical-grade cells, transgenic mouse technology, zebrafish and live-cell imaging.

“This is the first year of our affiliation with the Wallenberg Institute, and we expect it to be a long-term relationship,” Jaenisch states.

The meeting will open with the Presidential Symposium on June 24 from 1:15 p.m. to 3:15 p.m. The symposium sets the stage for the meeting with world-renowned speakers that include Nobel Prize-winner Shinya Yamanaka. It is also the platform for the formal recognition of the 2015 recipients of the McEwen Award for Innovation and the ISSCR Public Service Award. Another prestigious award, the ISSCR-BD Biosciences Outstanding Young Investigator Award, will be presented during Plenary VI on June 27 from 9 a.m. to 11:20 a.m. and followed by an award lecture.

“I look forward to the Presidential Symposium setting the tone for the entire program,” Jaenisch said. “A thread throughout will be the use of stem cells to drive our understanding of development and disease as we explore disease modeling, gene and tissue engineering technologies and other important advances that are bringing stem cells into the clinic.”

In fact, key clinical trials are now in the planning stage or have already begun, Jaenisch tells DDNews. “Macular degeneration trials are planned and underway,” he notes. In other developments, gene editing is allowing researchers to correct or add genes at will in both research applications and the clinic. In cancer, immune systems are being reprogrammed to kill cancer cells—for example, in melanoma and prostate disease. “Clinical applications are also being highlighted in workshops this year,” Jaenisch adds.

As for notable awards, “The ISSCR is thrilled to present the prestigious McEwen Award for Innovation to Irving Weissman and Hans Clevers, who have each made enormous contributions to stem cell science,” notes Dr. Hans Schöler of the Max Planck Institute for Molecular Biomedicine, chair of the ISSCR’s McEwen Awards selection committee. “Working in the blood and gut systems, respectively, and extending their findings in different tissues, they have defined the concepts and technologies that underpin many avenues of research. Each has made pioneering conceptual advances in disease modeling and regenerative medicine.”

“We are privileged to present our ISSCR-BD Biosciences Outstanding Young Investigator Award to Paul Tesar,” Jaenisch adds. “He has leveraged his understanding of mammalian development to create transformative stem cell-based technologies and to enable access to new areas of biology. His accomplishments advance our understanding of human health and would be impressive at any stage, but they are remarkable for someone so early in his career.”

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A scientist in protective laboratory attire examines a sample under a microscope, surrounded by digital overlays of DNA strands, molecular structures, scientific symbols, and data graphics.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
A scientist in protective laboratory attire examines a sample under a microscope, surrounded by digital overlays of DNA strands, molecular structures, scientific symbols, and data graphics.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
Blue microscopic illustration of spherical cells with textured surfaces against a dark background.
Explore how longitudinal single-cell profiling of whole blood can reveal immune signatures associated with CAR T cell therapy-related neurotoxicity.